R, K., A, A., LS, D., PM, T., A, P. C., F, B., . . . MA, S. (2024). Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM. Journal of the American College of Cardiology, 84(10), 904. https://doi.org/10.1016/j.jacc.2024.05.069
Chicago Style (17th ed.) CitationR, Khera, et al. "Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM." Journal of the American College of Cardiology 84, no. 10 (2024): 904. https://doi.org/10.1016/j.jacc.2024.05.069.
MLA (9th ed.) CitationR, Khera, et al. "Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM." Journal of the American College of Cardiology, vol. 84, no. 10, 2024, p. 904, https://doi.org/10.1016/j.jacc.2024.05.069.